Shanghai Institute Of Biological Products

This study tests a new vaccine called MVA-SIBP to see if it is safe and helps the body fight mpox (formerly monkeypox). About 180 people in Kinshasa, DRC, including children, teens, and adults, will receive either the vaccine or a placebo. Researchers will monitor side effects an…

This study tests a new injection called SIBP-A16 in 36 premature and full-term infants under 1 year old to see if it is safe and how the body processes it. The goal is to prevent respiratory syncytial virus (RSV), a common and serious lung infection in babies. The trial is double…

This study tests a new flu vaccine in 1200 adults aged 60 and older. It aims to see how well the vaccine boosts the body's defenses against the flu and checks for any side effects. Participants will receive one shot and be monitored for 30 days.